Hui Xu

Years Active: 2023-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Liang Zeng, Hui Xu, Shu-Hua Li, Shuo-Yu Xu, Kai Chen, Liang-Jun Qin, Lei Miao, Fang Wang, Ling Deng, Feng-Hua Wang, Le Li, Sha Fu, Na Liu, Ran Wang, Ying-Qing Li, Hai-Yun Wang
Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma. Journal for immunotherapy of cancer 11 (5) (2023)
Liang Zeng, Hui Xu, Shu-Hua Li, Shuo-Yu Xu, Kai Chen, Liang-Jun Qin, Lei Miao, Fang Wang, Ling Deng, Feng-Hua Wang, Le Li, Sha Fu, Na Liu, Ran Wang, Ying-Qing Li, Hai-Yun Wang
Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma. Journal for immunotherapy of cancer 11 (5) (2023)
Liang Zeng, Hui Xu, Shu-Hua Li, Shuo-Yu Xu, Kai Chen, Liang-Jun Qin, Lei Miao, Fang Wang, Ling Deng, Feng-Hua Wang, Le Li, Sha Fu, Na Liu, Ran Wang, Ying-Qing Li, Hai-Yun Wang
Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma. Journal for immunotherapy of cancer 11 (5) (2023)

Hui Xu.css-eqlu8i{font-size:small;padding-left:4px;}